BLEScath™ Intratracheal catheter for less invasive administration of pulmonary surfactant NRDS is a challenge mitigated by integrated scientific solutions. LONDON, Ontario, May 10, 2022 (GLOBE ...

Scientists at the University of Southampton's Zepler Institute for Photonics and Nanoelectronics are developing a rapid bedside test for diagnosing neonatal Respiratory Distress Syndrome (nRDS) in ...

LONDON, Ontario, May 10, 2022 (GLOBE NEWSWIRE) -- BLES Biochemicals Inc. is an established global player in providing innovative solutions for treating neonatal respiratory distress syndrome (NRDS ...